- Sample Preparation:
| Suggested Procedure |
- Sample Extraction:
| Recommended |
- Sensitivity:
 Data may differ slightly based on lot. | 0.07 ng/ml |
- Linear Range:
 Data may differ slightly based on lot. | 0.07 - 1.23 ng/ml |
- Cross Reactivity:
Peptide |
% |
CNP-22 (Human, Rat, Mouse, Porcine, Monkey) |
100 |
CNP-53 (Rat, Porcine) |
100 |
Urodilatin |
8.47 |
CNP-53 (1-29) (Rat, Porcine) |
0 |
α-ANP (1-28) (Human, Canine, Porcine, Bovine) |
0 |
ANF (Rat, Rabbit, Mouse) |
0 |
BNP-32 (Porcine) |
0 |
BNP-45 (Rat) |
0 |
Pro-BNP (22-46) (Human) |
0 |
Pro-BNP (47-76) (Human) |
0 |
Pro-BNP (1-46) (Human) |
0 |
N-Terminal Prepro-BNP(1-76)(Human) |
0 |
Endothelin-1 (Human, Rat, Porcine, Mouse, Canine, Bovine) |
0 |
Substance P |
0 |
DNP |
0 |
|
- Intra-assay variation:
| <10% |
- Inter-assay variation:
| <15% |
Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling.
C-Type Natriuretic Peptide Stimulates Ovarian Follicle Development.
Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa cells to promote meiotic resumption of pre-ovulatory oocytes.
Serum levels of natriuretic peptides in patients with Behcet's disease.
Aortic stiffness and aerobic exercise: mechanistic insight from microarray analyses.
Potentiation of C-type natriuretic peptide with ultrasound and microbubbles to prevent neointimal formation after vascular injury in rats.
Social Network Confirmation